These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of venous thromboembolism (VTE) – a common complication among patients with cancer who are at a markedly increased risk for morbidity and mortality.